CN Stock MarketDetailed Quotes

Shanghai Serum Bio-Technology (688163)

Watchlist

39.90
-1.54-3.72%

Market Closed May 21 15:00 CST

4.32BMarket Cap88.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Serum Bio-Technology (688163) Balance Sheet

All

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

Assets

Current assets

Money funds

-85.00%52.64M

-81.72%33.28M

-64.37%74.95M

-22.63%133.34M

182.79%350.92M

20.66%182.11M

72.43%210.36M

65.90%172.34M

-4.50%124.09M

-70.74%150.92M

Transactional financial assets

58.61%712.15M

19.29%764.91M

10.88%711.3M

-6.15%611.87M

-37.83%449M

-11.26%641.21M

-13.67%641.5M

-10.55%651.97M

-7.91%722.26M

73.03%722.59M

Notes receivable and accounts receivable

10.40%55.44M

25.68%46.1M

34.18%77.81M

65.74%98.58M

30.44%50.22M

62.05%36.68M

35.02%57.99M

14.20%59.48M

114.18%38.5M

194.73%22.63M

-Notes receivable

516.32%6.26M

--10.04M

--12.63M

----

--1.02M

----

-Accounts receivable

-0.04%49.18M

-1.68%36.06M

12.41%65.18M

65.74%98.58M

27.80%49.2M

62.05%36.68M

35.02%57.99M

14.20%59.48M

114.18%38.5M

194.73%22.63M

Other receivables (including interest and dividends)

35.82%1.24M

13.54%902.21K

-39.67%1.07M

88.09%978.19K

-18.10%909.96K

11.54%794.64K

66.17%1.77M

-48.09%520.06K

9.13%1.11M

-27.50%712.42K

-Other receivable

----

13.54%902.21K

----

88.09%978.19K

----

11.54%794.64K

----

-48.09%520.06K

----

-27.50%712.42K

Advance payment

-95.87%79.29K

-82.14%87.16K

-91.28%1.03M

-91.57%128.5K

72.89%1.92M

-67.23%488.11K

259.27%11.79M

40.19%1.52M

22.29%1.11M

190.54%1.49M

Inventories

-3.01%46.05M

-0.56%43.03M

5.47%38.76M

-1.04%42.41M

0.08%47.47M

-3.29%43.28M

-16.55%36.75M

-12.90%42.85M

-15.15%47.44M

-17.94%44.75M

Non-current assets due within one year

--11.7M

----

Other current assets

2.23%12.08M

2.86%12.15M

57.96%12.6M

115.30%20.6M

102.20%11.82M

102.51%11.81M

--7.98M

--9.57M

--5.84M

--5.83M

Total current assets

-2.29%891.37M

-0.46%912.16M

-5.23%917.51M

-3.23%907.9M

-2.99%912.26M

-3.43%916.36M

1.22%968.14M

0.23%938.25M

-5.02%940.36M

-4.83%948.93M

Non Current assets

Fixed assets

----

2.76%111.98M

----

-1.73%104.49M

----

86.77%108.98M

----

93.58%106.33M

----

-0.49%58.35M

Constru in process

----

93.57%80.99M

----

626.36%63.65M

----

-23.37%41.84M

----

-81.62%8.76M

----

26.59%54.6M

Productive biological assets

15.28%3.6M

23.73%3.58M

-6.01%3.71M

-31.91%3M

-31.81%3.12M

-16.45%2.89M

-21.88%3.95M

-8.63%4.4M

1.12%4.58M

4.00%3.46M

Intangible assets

-2.47%22.28M

-2.43%22.47M

-2.39%22.67M

-2.34%22.86M

-3.21%22.84M

-3.18%23.03M

-2.39%23.22M

-2.35%23.41M

-1.90%23.6M

-1.86%23.79M

Long deferred expense

-41.75%334.72K

-37.81%394.7K

-34.54%454.69K

-31.80%514.68K

-29.46%574.66K

-27.44%634.65K

-25.67%694.64K

-24.13%754.62K

-22.75%814.61K

-21.53%874.6K

Deferred tax assets

-7.94%7.38M

-13.91%6.89M

-18.45%8.07M

-11.64%8.54M

-19.52%8.02M

-19.29%8M

0.99%9.89M

-3.94%9.67M

63.52%9.96M

6.72%9.91M

Usufruct assets

16.55%4.14M

21.40%4.41M

-8.51%3.4M

-68.28%3.47M

-68.22%3.55M

-68.16%3.63M

-68.11%3.71M

-7.69%10.95M

-7.55%11.18M

-7.41%11.41M

Other non current assets

27.22%14.91M

-2.23%14.34M

93,120.00%20.97M

48.51%21.09M

52,000.00%11.72M

2,562.02%14.66M

0.00%22.5K

2,058.88%14.2M

0.00%22.5K

2,348.00%550.8K

Total non current assets

29.08%263M

20.32%245.05M

37.60%244.02M

17.71%227.63M

11.58%203.75M

13.44%203.67M

2.70%177.34M

13.50%193.38M

10.00%182.61M

5.97%179.54M

Total assets

3.44%1.15B

3.32%1.16B

1.40%1.16B

0.34%1.14B

-0.62%1.12B

-0.75%1.12B

1.45%1.15B

2.27%1.13B

-2.86%1.12B

-3.26%1.13B

Liabilities

Current liabilities

Notes payable and accounts payable

576.88%17.06M

1,157.50%16.49M

439.24%10.88M

-15.90%1.89M

-25.83%2.52M

-63.92%1.31M

-46.71%2.02M

-20.07%2.25M

-24.08%3.4M

-14.96%3.64M

-Accounts payable

576.88%17.06M

1,157.50%16.49M

439.24%10.88M

-15.90%1.89M

-25.83%2.52M

-63.92%1.31M

-46.71%2.02M

-20.07%2.25M

-24.08%3.4M

-14.96%3.64M

Contract liabilities

79.05%3.52M

44.39%3.18M

21.72%2.92M

105.68%3.73M

-25.54%1.97M

-24.66%2.2M

-20.16%2.39M

-30.05%1.81M

317.14%2.64M

47.33%2.93M

Salaries payable

370.41%8.15M

41.72%11.53M

55.80%6.4M

0.02%4.87M

-10.43%1.73M

5.88%8.14M

59.17%4.11M

3.83%4.87M

-15.74%1.94M

-0.23%7.69M

Taxs payable

-46.02%1.05M

-43.19%632.97K

16.05%7.17M

214.79%7.91M

32.47%1.95M

141.86%1.11M

153.18%6.17M

9.18%2.51M

-56.86%1.48M

-88.74%460.64K

Other payable (including interest and dividends)

-11.83%3.21M

-35.30%4.2M

-37.86%4.19M

-10.49%5.12M

-51.72%3.64M

-31.15%6.49M

-2.93%6.74M

-18.92%5.72M

69.71%7.54M

27.78%9.43M

-Dividend payable

16.24%22.9K

17.30%21.7K

19.39%19.7K

12.12%18.5K

83.33%16.5K

-Other payable

----

-35.46%4.18M

----

-10.58%5.1M

----

-31.24%6.47M

----

-18.99%5.7M

----

27.71%9.42M

Non current liabilities due within one year

159.06%767.63K

161.59%767.63K

7.41%309.16K

-60.15%309.16K

-60.93%296.32K

-61.31%293.45K

-79.04%287.82K

-43.49%775.86K

-44.76%758.43K

Other current liabilities

----

42.19%94.05K

21.72%87.46K

186.32%155.74K

-39.65%59.02K

-23.44%66.15K

-6.11%71.85K

-30.05%54.4K

680.84%97.79K

44.97%86.39K

Total current liabilities

177.45%33.77M

88.09%36.91M

46.56%31.95M

33.31%23.98M

-31.80%12.17M

-21.47%19.62M

7.91%21.8M

-13.91%17.99M

7.17%17.85M

-7.02%24.99M

Current liabilities

Estimate liabilities

--2.04M

----

Deferred tax liabilities

27.87%1.16M

40.77%1.28M

-84.08%848.78K

-83.71%868.52K

-83.33%908K

-4.10%5.33M

109.94%5.45M

-4.02%5.45M

Lease liabilities

3.32%4.18M

8.11%4.33M

-12.90%3.65M

-67.46%3.84M

-67.28%4.04M

-67.19%4M

-65.37%4.19M

-6.57%11.81M

-0.95%12.36M

-0.89%12.2M

Total non current liabilities

49.02%7.38M

55.68%7.65M

-52.74%4.5M

-72.52%4.71M

-72.19%4.95M

-72.17%4.91M

-46.09%9.53M

-5.82%17.14M

18.14%17.8M

-1.88%17.65M

Total liabilities

140.32%41.15M

81.60%44.55M

16.36%36.45M

-18.32%28.69M

-51.97%17.12M

-42.45%24.53M

-17.29%31.33M

-10.14%35.13M

12.38%35.65M

-4.96%42.63M

Shareholders equity

Paid-in capital

0.00%108.22M

Capital reserve funds

0.00%878.09M

0.76%878.09M

Surplus reserve funds

5.71%54.63M

12.79%51.68M

10.12%45.82M

Retained profit

18.68%72.29M

24.70%71.72M

6.17%87.1M

6.94%68.85M

10.36%60.91M

7.08%57.52M

17.28%82.03M

39.77%64.38M

-46.41%55.19M

-46.45%53.71M

Shareholders equity without minority interests

1.30%1.11B

1.57%1.11B

0.98%1.13B

0.94%1.11B

1.06%1.1B

0.89%1.1B

2.10%1.11B

2.73%1.1B

-3.29%1.09B

-3.19%1.09B

Total shareholder equity

1.30%1.11B

1.57%1.11B

0.98%1.13B

0.94%1.11B

1.06%1.1B

0.89%1.1B

2.10%1.11B

2.73%1.1B

-3.29%1.09B

-3.19%1.09B

Total liabilityies and equity

3.44%1.15B

3.32%1.16B

1.40%1.16B

0.34%1.14B

-0.62%1.12B

-0.75%1.12B

1.45%1.15B

2.27%1.13B

-2.86%1.12B

-3.26%1.13B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianzhi International Certified Public Accountants (Special General Partnership)

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023
Assets
Current assets
Money funds	-85.00%52.64M	-81.72%33.28M	-64.37%74.95M	-22.63%133.34M	182.79%350.92M	20.66%182.11M	72.43%210.36M	65.90%172.34M	-4.50%124.09M	-70.74%150.92M
Transactional financial assets	58.61%712.15M	19.29%764.91M	10.88%711.3M	-6.15%611.87M	-37.83%449M	-11.26%641.21M	-13.67%641.5M	-10.55%651.97M	-7.91%722.26M	73.03%722.59M
Notes receivable and accounts receivable	10.40%55.44M	25.68%46.1M	34.18%77.81M	65.74%98.58M	30.44%50.22M	62.05%36.68M	35.02%57.99M	14.20%59.48M	114.18%38.5M	194.73%22.63M
-Notes receivable	516.32%6.26M	--10.04M	--12.63M	----	--1.02M	----	----	----	----	----
-Accounts receivable	-0.04%49.18M	-1.68%36.06M	12.41%65.18M	65.74%98.58M	27.80%49.2M	62.05%36.68M	35.02%57.99M	14.20%59.48M	114.18%38.5M	194.73%22.63M
Other receivables (including interest and dividends)	35.82%1.24M	13.54%902.21K	-39.67%1.07M	88.09%978.19K	-18.10%909.96K	11.54%794.64K	66.17%1.77M	-48.09%520.06K	9.13%1.11M	-27.50%712.42K
-Other receivable	----	13.54%902.21K	----	88.09%978.19K	----	11.54%794.64K	----	-48.09%520.06K	----	-27.50%712.42K
Advance payment	-95.87%79.29K	-82.14%87.16K	-91.28%1.03M	-91.57%128.5K	72.89%1.92M	-67.23%488.11K	259.27%11.79M	40.19%1.52M	22.29%1.11M	190.54%1.49M
Inventories	-3.01%46.05M	-0.56%43.03M	5.47%38.76M	-1.04%42.41M	0.08%47.47M	-3.29%43.28M	-16.55%36.75M	-12.90%42.85M	-15.15%47.44M	-17.94%44.75M
Non-current assets due within one year	--11.7M	--11.7M	----	----	----	----	----	----	----	----
Other current assets	2.23%12.08M	2.86%12.15M	57.96%12.6M	115.30%20.6M	102.20%11.82M	102.51%11.81M	--7.98M	--9.57M	--5.84M	--5.83M
Total current assets	-2.29%891.37M	-0.46%912.16M	-5.23%917.51M	-3.23%907.9M	-2.99%912.26M	-3.43%916.36M	1.22%968.14M	0.23%938.25M	-5.02%940.36M	-4.83%948.93M
Non Current assets
Fixed assets	----	2.76%111.98M	----	-1.73%104.49M	----	86.77%108.98M	----	93.58%106.33M	----	-0.49%58.35M
Constru in process	----	93.57%80.99M	----	626.36%63.65M	----	-23.37%41.84M	----	-81.62%8.76M	----	26.59%54.6M
Productive biological assets	15.28%3.6M	23.73%3.58M	-6.01%3.71M	-31.91%3M	-31.81%3.12M	-16.45%2.89M	-21.88%3.95M	-8.63%4.4M	1.12%4.58M	4.00%3.46M
Intangible assets	-2.47%22.28M	-2.43%22.47M	-2.39%22.67M	-2.34%22.86M	-3.21%22.84M	-3.18%23.03M	-2.39%23.22M	-2.35%23.41M	-1.90%23.6M	-1.86%23.79M
Long deferred expense	-41.75%334.72K	-37.81%394.7K	-34.54%454.69K	-31.80%514.68K	-29.46%574.66K	-27.44%634.65K	-25.67%694.64K	-24.13%754.62K	-22.75%814.61K	-21.53%874.6K
Deferred tax assets	-7.94%7.38M	-13.91%6.89M	-18.45%8.07M	-11.64%8.54M	-19.52%8.02M	-19.29%8M	0.99%9.89M	-3.94%9.67M	63.52%9.96M	6.72%9.91M
Usufruct assets	16.55%4.14M	21.40%4.41M	-8.51%3.4M	-68.28%3.47M	-68.22%3.55M	-68.16%3.63M	-68.11%3.71M	-7.69%10.95M	-7.55%11.18M	-7.41%11.41M
Other non current assets	27.22%14.91M	-2.23%14.34M	93,120.00%20.97M	48.51%21.09M	52,000.00%11.72M	2,562.02%14.66M	0.00%22.5K	2,058.88%14.2M	0.00%22.5K	2,348.00%550.8K
Total non current assets	29.08%263M	20.32%245.05M	37.60%244.02M	17.71%227.63M	11.58%203.75M	13.44%203.67M	2.70%177.34M	13.50%193.38M	10.00%182.61M	5.97%179.54M
Total assets	3.44%1.15B	3.32%1.16B	1.40%1.16B	0.34%1.14B	-0.62%1.12B	-0.75%1.12B	1.45%1.15B	2.27%1.13B	-2.86%1.12B	-3.26%1.13B
Liabilities
Current liabilities
Notes payable and accounts payable	576.88%17.06M	1,157.50%16.49M	439.24%10.88M	-15.90%1.89M	-25.83%2.52M	-63.92%1.31M	-46.71%2.02M	-20.07%2.25M	-24.08%3.4M	-14.96%3.64M
-Accounts payable	576.88%17.06M	1,157.50%16.49M	439.24%10.88M	-15.90%1.89M	-25.83%2.52M	-63.92%1.31M	-46.71%2.02M	-20.07%2.25M	-24.08%3.4M	-14.96%3.64M
Contract liabilities	79.05%3.52M	44.39%3.18M	21.72%2.92M	105.68%3.73M	-25.54%1.97M	-24.66%2.2M	-20.16%2.39M	-30.05%1.81M	317.14%2.64M	47.33%2.93M
Salaries payable	370.41%8.15M	41.72%11.53M	55.80%6.4M	0.02%4.87M	-10.43%1.73M	5.88%8.14M	59.17%4.11M	3.83%4.87M	-15.74%1.94M	-0.23%7.69M
Taxs payable	-46.02%1.05M	-43.19%632.97K	16.05%7.17M	214.79%7.91M	32.47%1.95M	141.86%1.11M	153.18%6.17M	9.18%2.51M	-56.86%1.48M	-88.74%460.64K
Other payable (including interest and dividends)	-11.83%3.21M	-35.30%4.2M	-37.86%4.19M	-10.49%5.12M	-51.72%3.64M	-31.15%6.49M	-2.93%6.74M	-18.92%5.72M	69.71%7.54M	27.78%9.43M
-Dividend payable	16.24%22.9K	16.24%22.9K	16.24%22.9K	17.30%21.7K	19.39%19.7K	19.39%19.7K	19.39%19.7K	12.12%18.5K	83.33%16.5K	83.33%16.5K
-Other payable	----	-35.46%4.18M	----	-10.58%5.1M	----	-31.24%6.47M	----	-18.99%5.7M	----	27.71%9.42M
Non current liabilities due within one year	159.06%767.63K	161.59%767.63K	7.41%309.16K	-60.15%309.16K	-60.93%296.32K	-61.31%293.45K	-79.04%287.82K	-43.49%775.86K	-44.76%758.43K	-44.76%758.43K
Other current liabilities	----	42.19%94.05K	21.72%87.46K	186.32%155.74K	-39.65%59.02K	-23.44%66.15K	-6.11%71.85K	-30.05%54.4K	680.84%97.79K	44.97%86.39K
Total current liabilities	177.45%33.77M	88.09%36.91M	46.56%31.95M	33.31%23.98M	-31.80%12.17M	-21.47%19.62M	7.91%21.8M	-13.91%17.99M	7.17%17.85M	-7.02%24.99M
Current liabilities
Estimate liabilities	--2.04M	--2.04M	----	----	----	----	----	----	----	----
Deferred tax liabilities	27.87%1.16M	40.77%1.28M	-84.08%848.78K	-83.71%868.52K	-83.33%908K	-83.33%908K	-4.10%5.33M	-4.10%5.33M	109.94%5.45M	-4.02%5.45M
Lease liabilities	3.32%4.18M	8.11%4.33M	-12.90%3.65M	-67.46%3.84M	-67.28%4.04M	-67.19%4M	-65.37%4.19M	-6.57%11.81M	-0.95%12.36M	-0.89%12.2M
Total non current liabilities	49.02%7.38M	55.68%7.65M	-52.74%4.5M	-72.52%4.71M	-72.19%4.95M	-72.17%4.91M	-46.09%9.53M	-5.82%17.14M	18.14%17.8M	-1.88%17.65M
Total liabilities	140.32%41.15M	81.60%44.55M	16.36%36.45M	-18.32%28.69M	-51.97%17.12M	-42.45%24.53M	-17.29%31.33M	-10.14%35.13M	12.38%35.65M	-4.96%42.63M
Shareholders equity
Paid-in capital	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M	0.00%108.22M
Capital reserve funds	0.00%878.09M	0.00%878.09M	0.00%878.09M	0.00%878.09M	0.00%878.09M	0.00%878.09M	0.76%878.09M	0.76%878.09M	0.76%878.09M	0.76%878.09M
Surplus reserve funds	5.71%54.63M	5.71%54.63M	12.79%51.68M	12.79%51.68M	12.79%51.68M	12.79%51.68M	10.12%45.82M	10.12%45.82M	10.12%45.82M	10.12%45.82M
Retained profit	18.68%72.29M	24.70%71.72M	6.17%87.1M	6.94%68.85M	10.36%60.91M	7.08%57.52M	17.28%82.03M	39.77%64.38M	-46.41%55.19M	-46.45%53.71M
Shareholders equity without minority interests	1.30%1.11B	1.57%1.11B	0.98%1.13B	0.94%1.11B	1.06%1.1B	0.89%1.1B	2.10%1.11B	2.73%1.1B	-3.29%1.09B	-3.19%1.09B
Total shareholder equity	1.30%1.11B	1.57%1.11B	0.98%1.13B	0.94%1.11B	1.06%1.1B	0.89%1.1B	2.10%1.11B	2.73%1.1B	-3.29%1.09B	-3.19%1.09B
Total liabilityies and equity	3.44%1.15B	3.32%1.16B	1.40%1.16B	0.34%1.14B	-0.62%1.12B	-0.75%1.12B	1.45%1.15B	2.27%1.13B	-2.86%1.12B	-3.26%1.13B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	--	--	--	--	--	Unqualified opinion
Auditor	--	--	--	--	--	--	--	--	--	Tianzhi International Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Middle East conflict spreads to the stock market! How should investors respond?

According to Saudi sources, the United States and Iran will hold a new round of talks in Islamabad, the capital of Pakistan, after the end o Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm